Gait Retraining for Osteoarthritis
Trial Summary
What is the purpose of this trial?
The purpose of this proposed study is to investigate both the acute and chronic response of frontal plane knee moment after gait retraining and to assess the effects on the biomechanics of the contralateral side. Fifty-one patients diagnosed with tibiofemoral joint osteoarthritis (TFJ OA) will be recruited to participate in the proposed study. Participants will complete baseline trials to assess gait kinematic and kinetic parameters. Following baseline, each participant will perform six conditions of the foot progression gait or three conditions of the trunk lean gait modifications to determine which strategy is most effective in reducing frontal plane knee moment. Participants will then be randomized to either the control or experimental group based on their identified preferred strategy. Participants will complete eight gait retraining sessions using patient-specific gait modifications (tailored foot progression and tailored lateral trunk lean), or normal gait (control) during the training period. A fading feedback design will be implemented. Real-time haptic biofeedback will be provided on every step during the first two weeks and reduced by 25% every subsequent two weeks. No feedback will be provided during baseline and at testing sessions. Measures of pain and function will also be collected at all testing sessions. Variables of interest include ankle, knee, hip sagittal and frontal plane moments. In addition, sagittal and frontal plane impulse will also be assessed. Descriptive statistics will be calculated for foot progression angle, trunk lean angle, frontal and sagittal plane hip, knee, and ankle angles as well as moments. Descriptive statistics for frontal plane knee impulse will also be calculated. A multivariate analysis of variance (MANOVA) will be conducted to compare frontal plane knee moment, frontal plane knee impulse and the absolute sagittal plane moment will be compared across three groups at four different time points. Repeated measures analysis of variance (ANOVA) will be conducted to compare both sagittal and frontal plane joint biomechanics for the contralateral limb. The p-value will be set at .05.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Gait Retraining for Osteoarthritis?
Research shows that gait retraining can help reduce knee pain and joint load in people with knee osteoarthritis. Studies have found that adjusting walking patterns, like foot progression angle and step width, can decrease stress on the knee, potentially slowing the progression of osteoarthritis.12345
Is gait retraining safe for humans?
How is the Gait Retraining treatment different from other treatments for osteoarthritis?
Gait Retraining is unique because it focuses on changing the way a person walks to reduce stress on the knee joint, using techniques like adjusting foot angles and stride length, often with real-time feedback from wearable devices. This approach is different from traditional treatments that might focus on medication or physical therapy exercises, as it directly targets the mechanics of walking to alleviate knee pain and slow the progression of osteoarthritis.23458
Research Team
Nelson Cortes
Principal Investigator
Associate Professor
Eligibility Criteria
This trial is for adults aged 18-80 with knee osteoarthritis, who can walk unaided for at least 20 minutes. It's not suitable for those with a BMI over 35, recent back or leg surgery, knee treatments in the last six months, conditions affecting walking, cognitive impairments impacting motor learning, or if they use gait aids or certain orthotics.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline trials to assess gait kinematic and kinetic parameters
Gait Retraining Intervention
Participants perform 8 gait retraining sessions using patient-specific gait modifications or normal gait
Post-Intervention Testing
Over-ground gait analysis and treadmill walking performed to track skill acquisition
Follow-up
Follow-up testing to measure retention of prescribed gait modifications
Treatment Details
Interventions
- Gait Retraining (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
George Mason University
Lead Sponsor
Dr. Ali Andalibi
George Mason University
Chief Executive Officer
PhD in Microbiology and Molecular Genetics from UCLA
Dr. Chetan S. Shah
George Mason University
Chief Medical Officer since 2013
MD from Robert Wood Johnson Medical School